Michael R. McAlevey

Vice-Président Senior et Responsable Juridique

US·SEC (Form 4)

HCA Healthcare, Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (1 ops.)

€231k

▼ Sales (0 ops.)

—

Latest filing published 28 Aug 2026 for HCA Healthcare, Inc., €2.9M. Read the official filing

Filing timeline

BuySale

Michael R. McAlevey

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-6.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Michael R. McAlevey: trading record in brief

Michael R. McAlevey (senior executive) discloses dealings in HCA Healthcare, Inc. to SEC (Form 4). Over a trading history stretching from 29 April 2022 to 26 August 2026, the count stands at 8 filings.

On the market, this insider has only ever bought: 1 purchase, €231k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 4 option exercises.

On 28 August 2026 came the latest disclosure, a transaction for €2.9M in HCA Healthcare, Inc. The last purchase on record was published on 3 May 2022, which is 1,629 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.